Analytical Techniques for Structural Characterization of Proteins in Solid Pharmaceutical Forms: An Overview.

Therapeutic proteins as biopharmaceuticals have emerged as a very important class of drugs for the treatment of many diseases. However, they are less stable compared to conventional pharmaceuticals. Their long-term stability in solid forms, which is critical for product performance, depends heavily on the retention of the native protein structure during the lyophilization (freeze-drying) process and, thereafter, in the solid state.

Discovery of 'click' 1,2,3-triazolium salts as potential anticancer drugs.

Background: In order to increase the effectiveness of cancer treatment, new compounds with potential anticancer activities are synthesized and screened. Here we present the screening of a new class of compounds, 1-(2-picolyl)-, 4-(2-picolyl)-, 1-(2-pyridyl)-, and 4-(2-pyridyl)-3-methyl-1,2,3-triazolium salts and 'parent' 1,2,3-triazole precursors.

Methods: Cytotoxic activity of new compounds was determined by spectrophotometric MTT assay on several tumour and one normal cell line.

Ru, Ir and Os mesoionic carbene complexes: efficient catalysts for transfer hydrogenation of selected functionalities.

Pyridine-appended triazolylidene donors have been recently used as ligands in various homogeneous catalytic processes. We present here a new pyrimidine substituted triazolium salt which was prepared and used in the coordination to Ru and Os. The new triazolium salt and the obtained complexes were characterized by multinuclear NMR spectroscopy.

A mesoionic bis(Py-tzNHC) palladium(II) complex catalyses "green" Sonogashira reaction through an unprecedented mechanism.

A novel bis(pyridyl-functionalized 1,2,3-triazol-5-ylidene)-palladium(II) complex [Pd(Py-tzNHC)2](2+) catalyses the copper-, amine-, phosphine-, and additive-free aerobic Sonogashira alkynylation of (hetero)aryl bromides in water as the only reaction solvent. The catalysis proceeds along two connected Pd-cycles with homogeneous bis-carbene Pd(0) and Pd(II) species, as demonstrated by electrospray ionization mass spectrometry.

Ru(II), Os(II), and Ir(III) complexes with chelating pyridyl-mesoionic carbene ligands: structural characterization and applications in transfer hydrogenation catalysis.

Chelating ligands with one pyridine donor and one mesoionic carbene donor are fast establishing themselves as privileged ligands in homogeneous catalysis. The synthesis of several new Ir(III)-Cp*- and Os(II)-Cym complexes (Cp* = pentamethylcyclopentadienyl, Cym = p-cymene=4-isopropyl-toluene) derived from chelating pyridyltriazolylidenes where the additional pyridine donor was incorporated via the azide part of the triazole is presented. Furthermore, different 4-substituted phenylacetylene building blocks have been used to introduce electronic fine-tuning in the ligands.

Catalytic oxygenation of sp3 "C-H" bonds with Ir(III) complexes of chelating triazoles and mesoionic carbenes.

Cp*-Ir(III) complexes with additional chelating ligands are known active pre-catalysts for the oxygenation of C-H bonds. We present here eight examples of such complexes where the denticity of the chelating ligands has been varied from the well-known 2,2'-bpy through pyridyl-triazole, bi-triazole to ligands containing pyridyl-triazolylidene, triazolyl-triazolylidene and bi-triazolylidenes. Additionally, we also compare the catalytic results to complexes containing chelating cyclometallated ligands with additional triazole or triazolylidene donors.

A selective approach to pyridine appended 1,2,3-triazolium salts.

A selective and highly efficient strategy to obtain a library of pyridine appended 1,4-disubstituted-3-methyl-1,2,3-triazolium salts is described. It features pyridine nitrogen protection at click-derived pyridyl-triazoles through N-oxidation with subsequent N3 alkylation of the triazole ring and deprotection. Triazolium salts are obtained in high yield and purity in either a stepwise or one-pot protocol.